Shaanxi Kanghui Pharm Co Ltd (603139) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Based on the latest financial reports, Shaanxi Kanghui Pharm Co Ltd (603139) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥7.14 Million ≈ $1.04 Million USD) by net assets (CN¥745.41 Million ≈ $109.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603139 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Shaanxi Kanghui Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Shaanxi Kanghui Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shaanxi Kanghui Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shaanxi Kanghui Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Golden Friends TWO:4506	0.089x
Zhejiang Henglin Chair Industry Co Ltd Class A SHG:603661	0.057x
Citic Guoan Wine Co Ltd SHG:600084	0.005x
Shore Bancshares Inc NASDAQ:SHBI	0.072x
Shandong Luyang Share Co Ltd SHE:002088	0.000x
WA1 Resources Ltd AU:WA1	-0.012x
CHINA VANKE CO.LTD H YC 1 F:18V	N/A
Lander Sports Development Co Ltd SHE:000558	-0.135x

Annual Cash Flow Conversion Efficiency for Shaanxi Kanghui Pharm Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Shaanxi Kanghui Pharm Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Shaanxi Kanghui Pharm Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥568.98 Million ≈ $83.26 Million	CN¥-16.72 Million ≈ $-2.45 Million	-0.029x	-171.46%
2024-12-31	CN¥906.90 Million ≈ $132.71 Million	CN¥37.29 Million ≈ $5.46 Million	0.041x	+158.14%
2023-12-31	CN¥1.02 Billion ≈ $149.25 Million	CN¥-72.13 Million ≈ $-10.56 Million	-0.071x	-243.87%
2022-12-31	CN¥1.03 Billion ≈ $150.13 Million	CN¥50.43 Million ≈ $7.38 Million	0.049x	+638.84%
2021-12-31	CN¥1.12 Billion ≈ $163.16 Million	CN¥7.42 Million ≈ $1.09 Million	0.007x	-92.38%
2020-12-31	CN¥1.07 Billion ≈ $157.00 Million	CN¥93.72 Million ≈ $13.71 Million	0.087x	-17.40%
2019-12-31	CN¥1.02 Billion ≈ $148.79 Million	CN¥107.53 Million ≈ $15.73 Million	0.106x	+65.34%
2018-12-31	CN¥979.31 Million ≈ $143.30 Million	CN¥62.64 Million ≈ $9.17 Million	0.064x	+33.81%
2017-12-31	CN¥912.11 Million ≈ $133.47 Million	CN¥43.60 Million ≈ $6.38 Million	0.048x	-65.16%
2016-12-31	CN¥522.81 Million ≈ $76.50 Million	CN¥71.72 Million ≈ $10.49 Million	0.137x	+120.22%
2015-12-31	CN¥457.58 Million ≈ $66.96 Million	CN¥28.50 Million ≈ $4.17 Million	0.062x	+8.38%
2014-12-31	CN¥395.37 Million ≈ $57.86 Million	CN¥22.72 Million ≈ $3.33 Million	0.057x	-51.42%
2013-12-31	CN¥332.63 Million ≈ $48.67 Million	CN¥39.35 Million ≈ $5.76 Million	0.118x	+54.43%
2012-12-31	CN¥210.43 Million ≈ $30.79 Million	CN¥16.12 Million ≈ $2.36 Million	0.077x	--

About Shaanxi Kanghui Pharm Co Ltd

SHG:603139 China Drug Manufacturers - Specialty & Generic

Market Cap

$660.77 Million

CN¥4.52 Billion CNY

Market Cap Rank

#10995 Global

#3093 in China

Share Price

CN¥45.21

Change (1 day)

+2.45%

52-Week Range

CN¥20.27 - CN¥45.21

All Time High

CN¥45.21